Search

Dipaparkan jumlah carian 331 - 340 daripada 1546
Direktori Sistem Pendispensan Ubat Bersepadu (SPUB) 2021
Senarai fasiliti farmasi Kementerian Kesihatan Malaysia yang menyediakan perkhidmatan Sistem Pendispensan Ubat Bersepadu (SPUB) di Malaysia. Direktori SPUB (mengikut negeri) yang dilampirkan di...
Kategori: Dokumen | Tarikh: 19 Feb 2021
Direktori Perkhidmatan Nilai Tambah Farmasi (Value Added Service, VAS) 2021
Senarai fasiliti farmasi Kementerian Kesihatan Malaysia yang menyediakan Perkhidmatan Nilai Tambah Farmasi (Value Added Services, VAS). Perkhidmatan ini diperkenalkan bagi memudahkan pengambilan...
Kategori: Dokumen | Tarikh: 16 Jun 2021
Pharmacy Value Added Service (VAS) Directory 2021
List of Ministry of Health's pharmacy facilities that provide pharmacy Value Added Services (VAS). The services were introduced to facilitate patients in collecting their monthly medicines supply...
Kategori: Dokumen | Tarikh: 16 Jun 2021
Notis Permohonan Iklan KKLIU Sepanjang Perintah Kawalan Pergerakan (PKP)
Kategori: Berita | Tarikh: 25 Jan 2021
Nasihat Kementerian Kesihatan Malaysia Berhubung Tuntutan Pencegahan Atau Rawatan Covid-19
  Sehingga kini masih belum ada vaksin Covid-19 yang dibenarkan untuk dijual secara sah di pasaran Malaysia. Berhati-hatilah jika anda menemui atau ditawarkan bekalan vaksin Covid-19 oleh...
Kategori: Berita | Tarikh: 17 Feb 2021
Guidance On The Requirement To Import, Handle, Store And Distribute COVID-19 Vaccines In Malaysia
Tujuan dokumen ini adalah untuk memberi panduan mengenai keperluan untuk mengimport, mengendali, menyimpan dan mengedarkan vaksin COVID-19 di Malaysia bagi memastikan kualiti, keselamatan dan...
Kategori: Dokumen | Tarikh: 15 Jan 2021
Guidance On The Requirement To Import, Handle, Store And Distribute COVID-19 Vaccines In Malaysia
The purpose of this document is to provide guidance on the requirement to import, handle, store and distribute COVID-19 vaccines in Malaysia to ensure quality, safety dan efficacy of the products are...
Kategori: Dokumen | Tarikh: 15 Jan 2021
Reports of Kidney-Related and Liver-Related Adverse Reactions after Consumption of Ganoderma (Lingshi / Reishi) Products
Untuk makluman, pihak Seksyen Farmakovigilans (NPRA) telah menerbitkan satu artikel bertajuk NPRA Updates on Reports of Kidney-Related and Liver-Related Adverse Reactions after Consumption of...
Kategori: Berita | Tarikh: 15 Jan 2021
Jemputan Unified Public Consultation (UPC): Pelaksanaan Mekanisme Harga Ubat & Kajian Cost Benefit Analysis (CBA)
Sukacita dimaklumkan bahawa Program Perkhidmatan Farmasi, Kementerian Kesihatan Malaysia (KKM) sedang mengadakan sesi penerangan secara atas talian berkaitan status terkini Mekanisme Harga Ubat dan...
Kategori: Agenda | Tarikh: 15 Jan 2021
Unified Public Consultation (UPC): Implementation of Medicines Price Mechanism & Cost-Benefit Analysis
We are pleased to inform that the Pharmaceutical Services Program, Ministry of Health Malaysia (MOH) is ​currently ​holding multiple online briefing session on the latest status of Medicines ...
Kategori: Agenda | Tarikh: 15 Jan 2021

Pages